Posted by Michelle | Comments (0)

T. Reed Stephens

Reed Stevens was interviewed for the American Airline's Forbes Business & Technology Channel for a show covering the following topics: “Designing a 21st Century Health Care System, The New Medicare Law, The Medicaid Law, Health Care Litigation, The Medicine Equity & Drugs Safety Act II & The Pharmaceutical Industry’s Security Measures to Protect the Integrity of Prescription Drugs and the Drug Distribution Network.”

To listen to Mr. Steven's interview click on the Healthcare icon on Professional Recruiter's Web site.

Mr. Stephens, a partner with the Sonnenschein firm in Washington, D.C., practices in the firm's national health care practice. A former attorney with the Department of Justice, he was lead or co-lead counsel in some 60 investigations, the majority involving allegations of health care fraud against the Medicare and Medicaid programs, TRICARE, the Department of Defense, and the Department of Veteran's Affairs. Mr. Stephens was lead/co-lead counsel in over a dozen fraud matters that resulted in multi-million dollar recoveries to the United States. Of the $6 billion in recoveries collected by the Department of Justice under the qui tam provisions of the False Claims Act in the seventeen years since the 1986 amendments to the statute, over 10% of that total was recovered in Mr. Stephens' cases. These investigations -- many of which resulted in complex, civil/criminal federal/state global settlements -- involved a host of providers and suppliers, including pharmaceutical manufacturers, hospitals and home health agencies.

In the pharmaceutical area, for example, Mr. Stephens was the lead or co-lead counsel in the recent whistleblower investigations and ground-breaking Average Wholesale Price and Medicaid Rebate settlements involving Bayer, TAP Pharmaceuticals, Warner-Lambert, Dey Laboratories, and AstraZeneca. As a result of his involvement in these cases, Mr. Stephens received a "Special Commendation Award" from the Department of Justice in December 2002. Mr. Stephens also worked closely with the Department of Health and Human Services' Office of Counsel to the Inspector General to develop the corporate integrity agreements applied to TAP Pharmaceuticals, Bayer, Pfizer and contributed significantly to the Inspector General's first ever "Guidance to Pharmaceutical Manufacturers."

Mr. Stephens is a nationally recognized expert in the pharmaceutical fraud and abuse and corporate compliance area -- speaking frequently to private industries at conferences on a wide range of topics, including the federal Civil False Claims Act, the federal and state Anti-kickback laws, and the development and implementation of health care corporate compliance programs.

Mr. Stephens is a former instructor of government attorneys at the Department of Justice's National Advocacy Center.